Briviact 25 mg/1
brivaracetam · TABLET, FILM COATED · UCB, Inc.
No Recall History
Plain English
Briviact is a tablet, film coated containing brivaracetam at 25 mg/1, taken oral. Manufactured by UCB, Inc..
Key Facts
- Brand Name
- Briviact
- Generic Name
- brivaracetam
- NDC Code (Product)
50474-470- Manufacturer
- UCB, Inc.
- Strength
- 25 mg/1
- Dosage Form
- TABLET, FILM COATED
- Route
- ORAL
- Marketing Status
- DEA Schedule
- Schedule V (Controlled)
- Application #
- NDA205836
- Drug Class
- Epoxide Hydrolase Inhibitors [MoA]
- Marketing Start
- 05/12/2016
Recall History
No Recall HistoryFrequently Asked Questions
What is Briviact used for?
Briviact contains brivaracetam. It is a tablet, film coated taken oral. Consult your doctor for specific uses.
Is Briviact a controlled substance?
Yes, Briviact is classified as CV under the DEA Controlled Substances Act.
What is the generic name for Briviact?
The generic name for Briviact is brivaracetam. There are 10 other brand versions of brivaracetam.
What is the NDC code for Briviact 25 mg/1?
The NDC (National Drug Code) for Briviact 25 mg/1 is 50474-470, listed by UCB, Inc..
Other Briviact Dosages
Other Brivaracetam Brands
See all →- brivaracetam10 mg/mL72205-033
- Brivaracetam50 mg/5mL72205-272
- Brivaracetam oral Solution10 mg/mL71921-410
- brivaracetam75 mg/173473-907
- Brivaracetam50 mg/160505-4725
- Brivaracetam Oral Solution10 mg/mL67877-904
- brivaracetam100 mg/170771-1758
- brivaracetam25 mg/172205-268
- brivaracetam10 mg/173473-904
- Brivaracetam25 mg/160505-4724
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)